378
Participants
Start Date
January 11, 2021
Primary Completion Date
March 17, 2022
Study Completion Date
March 17, 2022
APP13007, 0.05%
APP13007 eye drop, 0.05%
Matching Vehicle Placebo for APP13007, 0.05%
Matching vehicle placebo eye drop
Raymond Fong, MD, PC, New York
Bucci Laser Vision Institute, Wilkes-Barre
Carolina Eye Associates, Southern Pines
Coastal Research Associates, LLC, Roswell
International Eye Associates, PA, Ormond Beach
Levenson Eye Associates, Jacksonville
Newsom Eye and Laser Center, Sebring
Senior Health Services, Louisville
Eye Physicians, LLC, Columbus
Midwest Cornea Associates, LLC, Carmel
Jacksoneye SC, Columbus
Comprehensive Eye Care, Ltd., Washington
Ophthalmology Consultants, Ltd., St Louis
Silverstein Eye Centers, PC, Kansas City
Houston Eye Associates, Houston
Advanced Laser Vision and Surgical Institute, Houston
R and R Eye Research, LLC, San Antonio
San Antonio Eye Center, San Antonio
Keystone Research Ltd., Austin
Lake Travis Eye and Laser Center, Lakeway
Retina Research Center, PLLC, Austin
Icon Eye Care, Grand Junction
Stacy R. Smith, MD, PC, Salt Lake City
Schwartz Laser Eye Center, Scottsdale
NV Eye Surgery, Henderson
Center For Sight, Las Vegas
SoCal Eye Physicians and Associates, Long Beach
Global Research Management, Glendale
North Valley Eye Medical Group, Inc., Mission Hills
Pendleton Eye Center, Oceanside
Inland Eye Specialists, Hemet
LoBue Laser and Eye Medical Center, Inc., Murrieta
Martel Eye Medical Group, Rancho Cordova
Shasta Eye Medical Group, Inc., Redding
Centro Oftalmologico Metropolitano, San Juan
Lead Sponsor
Formosa Pharmaceuticals, Inc.
INDUSTRY